Statement from Apiject Systems, Corp.
October 20, 2026 — Apiject applauds President Trump and First Lady Melania Trump for their initiative to improve the health and well-being of women and girls at every stage of life. We strongly support the Administration’s commitment to turning medical research and scientific advances into better, more accessible healthcare for the American people.
This commitment is closely aligned with Apiject’s mission to improve access to safe, effective, and affordable medicines. Medical breakthroughs can change lives, but only if patients can access the treatments they need. Improving healthcare requires not only developing better medicines but also ensuring that those medicines are affordable and reliably available.
For the past several years, Apiject has worked with the U.S. Government to strengthen America’s ability to respond to public health emergencies and bring the manufacturing of essential medicines back to the United States. Our work uses American innovation to fundamentally reduce the cost of manufacturing of ready-to-use finished medicines, so that American companies can once again produce them profitably, at prices competitive with China and India.
We welcome this initiative and share the Administration’s commitment to ensuring that advances in medicine translate into better health outcomes for women and girls across America. Making essential medicines more affordable, accessible, and reliably available is an important part of fulfilling that commitment.
Jon Ellenthal, President
Molly Weaver, PhD, Chief Operating Officer